Kubota Glass
Myopia Control
Clinical Trial & Product Eng.Active
Key Facts
Indication
Myopia Control
Phase
Clinical Trial & Product Eng.
Status
Active
Companies
About Kubota Vision
Kubota Vision is a clinical-stage biotech focused on ophthalmic diseases, advancing a hybrid pipeline of small molecule therapeutics and novel medical devices. Its lead asset is emixustat HCl, in development for Stargardt disease and proliferative diabetic retinopathy, while its device portfolio includes the Kubota Glass for myopia control and remote retinal monitoring systems. The company leverages its position within the Kubota Pharma Group to pursue a dual strategy of treating retinal diseases and managing common refractive errors with high-tech solutions.
View full company profileAbout Kubota Pharmaceutical
A Japanese biotech company developing small molecule drugs and devices to treat and cure blinding diseases.
View full company profileTherapeutic Areas
Other Myopia Control Drugs
| Drug | Company | Phase |
|---|---|---|
| Myopia Control Studies | Oculus Research | Not Applicable (Service Provider) |